Oslo Cancer Cluster Incubator together with the Norwegian Industrial Property Office (Patentstyret) and Inven2 kindly invite researchers, clinicians and start-ups to learn more about securing IPR in oncology projects. PROGRAM Moderator: Sigrid Fossheim, Norwegian Cancer Society08.00 ▸ Breakfast and networking08.30 ▸ Welcome and latest update from Oslo Cancer Cluster IncubatorKetil Widerberg, General Manager, Oslo Cancer […]

Oslo Cancer Cluster Incubator is pleased to invite you to our Breakfast Seminar on “How to raise private capital – learn the tricks of the trade from the experts”. Download program here 08:00 – 08:15 Registration & Breakfast 08:15 – 08:30 Welcome & Update on Oslo Cancer Cluster IncubatorBjørn Klem, Coming General Manager Oslo Cancer […]

Drug development of various types of biologic products is a complex and multidisciplinary process. The development integrates knowledge of the underlying disease, target identification, principles on biologics safety, planning strategy for toxicology and clinical studies incorporating the key aspects of manufacturing and controls. This three-day course provides insights into all parts that should be addressed […]

How can the Norwegian Medicines Agency (NMA) provide value to your company? Presentation by: Lars Petter Akselsen, Head of Innovation Services NMA We all work in a regulated innovation environment and an important player in this field is the Norwegian Medicines Agency. Innovative technology is entering medical research at an increasing speed and life science […]